AVP-786 matching placebo, AVP-786
20-AVP-786-307
Phase 3 small_molecule active
Quick answer
AVP-786 matching placebo, AVP-786 for Agitation in Patients With Dementia of the Alzheimer's Type is a Phase 3 program (small_molecule) at Otsuka Novel Products GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Otsuka Novel Products GmbH
- Indication
- Agitation in Patients With Dementia of the Alzheimer's Type
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active